UNSPSC 85445607: The diagnosis of alpha-adrenoreceptor antagonists

In this classification, this covers the group of activities that yields a diagnosis of alpha-adrenoreceptor antagonists, not elsewhere classified. Alpha-adrenoreceptor antagonists, not elsewhere classified is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y51.6.

UNSPSC 85445607 — The diagnosis of alpha-adrenoreceptor antagonists — is a Commodity code that shows little relevant recent state and local procurement activity. The code's nominal scope concerns pharmaceutical diagnostics, but the three most recent opportunities tagged to it involve healthcare information systems and staffing services that are unrelated to alpha-adrenoreceptor antagonist diagnosis. San Mateo Medical Center posted an RFP for Diagnostic Imaging PACS (Picture Archiving and Communication System) implementation with a response deadline of October 21, 2026; Birdville Independent School District in Texas posted a request for special education contracted services due the same date; and Santa Clara County Health System posted a qualification vehicle for temporary health professional staffing across ancillary clinical categories, with proposals due October 7, 2026. None of these solicitations align with the code's stated purpose.

The mismatch between the code's narrow pharmaceutical-diagnostic scope and the actual state and local procurement activity tagged to it indicates that either the code has been misapplied by the issuing bodies or the code does not represent genuine state and local buying patterns in this category. Business development professionals should verify whether opportunities under this code are worth pursuing by confirming the actual commodity or service scope with the issuing body before investing in proposal development, as the current tagging does not reflect meaningful alignment with the code definition.